Inhibition of the ubiquitin-proteasome system by a bioactivatable compound
T. A. Giovannucci, F. Salomons, M. Haraldsson, L. Elfman, M. Wickstrom, P. Young, T. Lundback, J. Eirich, M. Altun, R. Jafari, A.-L. Gustavsson, J. I. Johnson, N. Dantuma
The paper identifies CBK77, a bioactivatable compound that inhibits the ubiquitin-proteasome system by targeting NQO1, leading to cell death in cancer cells.
bioRxiv · Mar 16, 2021Cell Biology